NCT00766155 Chemotherapy and Radiation Therapy Before Surgery Followed by Capecitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE3
NCT00755534 Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC Status TERMINATED Phase PHASE2
NCT00749450 Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00745134 Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal Cancer Status TERMINATED Phase PHASE2
NCT00741260 Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00732810 SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) Status COMPLETED Phase PHASE2
NCT00726687 Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT00719550 AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00718913 Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer Status COMPLETED Phase PHASE2
NCT00717990 Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment Status TERMINATED Phase PHASE2
NCT00717197 Study of Capecitabine to Treat Recurrent High Grade Gliomas Status COMPLETED Phase PHASE2
NCT00707278 Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00706069 Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00686166 S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer Status COMPLETED Phase PHASE2
NCT00684983 Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00684216 Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00680901 LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib Status COMPLETED Phase PHASE3
NCT00678535 Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer Status COMPLETED Phase PHASE3
NCT00675012 NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2